Oak Harvest Investment Services Regeneron Pharmaceuticals, Inc. Transaction History

Oak Harvest Investment Services

$694 Million
Q3 2024

A detailed history of Oak Harvest Investment Services transactions in Regeneron Pharmaceuticals, Inc. stock. As of the latest transaction made, Oak Harvest Investment Services holds 2,779 shares of REGN stock, worth $2.06 Million. This represents 0.42% of its overall portfolio holdings.

Number of Shares

2,779

Previous 2,212 25.63%

Holding current value

$2.06 Million

Previous $2.32 Million 25.69%

% of portfolio

0.42%

Previous 0.36%

11 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Oct 25, 2024	BUY	$1024.09 - $1201.76 $580,659 - $681,397	567 Added 25.63%	2,779 $2.92 Million
Q2 2024 Oct 24, 2024	BUY	$883.2 - $1071.19 $384,192 - $465,967	435 Added 24.48%	2,212 $2.32 Million
Q2 2024 Jul 22, 2024	BUY	$883.2 - $1071.19 $119,232 - $144,610	135 Added 10.57%	1,412 $1.48 Million
Q1 2024 Oct 24, 2024	BUY	$902.69 - $993.35 $329,481 - $362,572	365 Added 25.85%	1,777 $1.71 Million
Q1 2024 Apr 19, 2024	BUY	$902.69 - $993.35 $59,577 - $65,561	66 Added 5.45%	1,277 $1.23 Million
Q4 2023 Jan 12, 2024	BUY	$775.18 - $881.7 $191,469 - $217,779	247 Added 25.62%	1,211 $1.06 Million
Q3 2023 Oct 25, 2023	SELL	$692.45 - $844.37 $8,309 - $10,132	-12 Reduced 1.23%	964 $793,000
Q2 2023 Jul 17, 2023	SELL	$700.03 - $830.35 $1.24 Million - $1.48 Million	-1,777 Reduced 64.55%	976 $701,000
Q1 2023 Apr 20, 2023	SELL	$680.49 - $826.97 $53,758 - $65,330	-79 Reduced 2.79%	2,753 $2.26 Million
Q4 2022 Jan 24, 2023	BUY	$705.89 - $766.39 $40,941 - $44,450	58 Added 2.09%	2,832 $0
Q3 2022 Oct 14, 2022	BUY	$573.97 - $724.32 $1.59 Million - $2.01 Million	2,774 New	2,774 $1.91 Million

Others Institutions Holding REGN

# of Institutions

1,535

Shares Held

83.8M

Call Options Held

1.22M

Put Options Held

1.51M

View Full List

About REGENERON PHARMACEUTICALS, INC.

Ticker REGN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,190,000
Market Cap $79.3B
Description
Regeneron Pharmaceuticals, Inc. discovers, invents, develops, manufactures, and commercializes medicines for treating various diseases worldwide. The company's products include EYLEA injection to treat wet age-related macular degeneration and diabetic macular edema; myopic choroidal neovascularization; and diabetic retinopathy, as well as macula...

More about REGN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Oak Harvest Investment Services, based on Form 13F filings with the SEC.

News

Stay updated on Oak Harvest Investment Services with notifications on news.

Account

Oak Harvest Investment Services Regeneron Pharmaceuticals, Inc. Transaction History